Palliative radiotherapy of bone metastasis

Area of Science:

• Oncology
• Radiation Oncology
• Palliative Care

Background:

• Bone metastases significantly impact patient quality of life, primarily through pain.
• Radiotherapy is a common treatment modality for managing pain associated with bone metastases.
• Understanding the efficacy and re-treatment patterns of radiotherapy is crucial for optimizing palliative care.

Purpose of the Study:

• To evaluate the effectiveness of radiotherapy in providing pain relief for bone metastases.
• To assess the need for re-irradiation in prostate cancer patients with bone metastases.
• To determine the optimal radiation dosage and intervals for pain management.

Main Methods:

• Analysis of 226 metastatic bone tumor sites treated with radiotherapy (1981-1984).
• Analysis of 157 bone metastasis sites in prostate cancer patients treated with radiotherapy (1970-1988).
• Evaluation of pain relief, re-irradiation rates, and treatment intervals.

Main Results:

• Approximately 90% of patients experienced pain relief within the 20Gy to 30Gy dose range.
• Minimal differences in efficacy were observed across various primary tumor types and histological subtypes.
• Only 15% of observed prostate cancer sites required re-irradiation after 6 months due to recurring pain.

Conclusions:

• Radiotherapy is a highly effective palliative treatment for bone metastases, offering significant pain relief.
• The established dosage range (20-30Gy) is generally sufficient, with low rates of re-irradiation needed.
• Prompt and safe pain relief through radiotherapy is vital for improving the quality of life in patients with bone metastases, especially in prostate cancer.